Jaguar Health (JAGX) Receivables - Net (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Receivables - Net data on file, last reported at $68000.0 in Q1 2026.

• Receivables - Net for Q1 2026 came in at $68000.0, down 94.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $68000.0 (down 94.44% YoY), and the FY2025 annual result was $1.5 million, changed 0.39% from the prior year.
• Receivables - Net eased to $68000.0 in Q1 2026 per JAGX's latest filing, from $1.5 million in the prior quarter.
• Over five years, Receivables - Net peaked at $2.0 million in Q4 2023 and troughed at $68000.0 in Q1 2026.
• A 5-year average of $1.4 million and a median of $1.5 million in 2024 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2024 and 2026: Receivables - Net surged 53.19% in 2024, then sank 94.44% in 2026.
• A 5-year view of Receivables - Net shows it stood at $1.9 million in 2022, then rose by 4.68% to $2.0 million in 2023, then decreased by 22.37% to $1.5 million in 2024, then fell by 0.39% to $1.5 million in 2025, then sank by 95.53% to $68000.0 in 2026.
• Business Quant data shows JAGX's Receivables - Net at $68000.0 in Q1 2026, $1.5 million in Q4 2025, and $1.4 million in Q3 2025.